PTX 2.50% 3.9¢ prescient therapeutics limited

Ann: Two PTX abstracts accepted at prestigious ISCT conference, page-12

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 240 Posts.
    lightbulb Created with Sketch. 30
    I am a long-term holder and still quite bullish on PTX but I think there is some overhyping this conference abstract thing. I have presented at medical conference and submitted abstracts to "prestigious" journals in a previous life. It's really not a big deal. Some senior researcher says to a junior - "Rustle up an abstract about something you are doing" and lets submit it to this conference. There is really minimal peer review of the 100's or 1000's of abstracts submitted and most all are published in a conference edition of some or other journal, even well-regarded. I have previously had to search long and hard to even find my abstract in the journal. I think the non-executive appointment sounds better news.
 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
(20min delay)
Last
3.9¢
Change
-0.001(2.50%)
Mkt cap ! $31.40M
Open High Low Value Volume
4.1¢ 4.1¢ 3.9¢ $72.73K 1.802M

Buyers (Bids)

No. Vol. Price($)
5 436541 3.9¢
 

Sellers (Offers)

Price($) Vol. No.
4.1¢ 560576 1
View Market Depth
Last trade - 15.59pm 15/11/2024 (20 minute delay) ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.